Digipath
CHM Cannabis
Home > Boards > US OTC > Cannabis >

Nemus Bioscience, Inc. (NMUS)

NMUS RSS Feed
Add NMUS Price Alert      Hide Sticky   Hide Intro
Moderator: zenvesting, Southern Gal
Search This Board: 
Last Post: 12/11/2018 9:59:50 PM - Followers: 138 - Board type: Free - Posts Today: 0


 

 NEMUS BIOSCIENCE™ provides pharmaceutical research and development services focused on discovering, developing, and commercializing new chemical entities from a class of chemically diverse compounds. We develop novel and proprietary classes of product candidates that are designed to improve therapeutic options through enhanced chemical engineering that allow drug candidates to have more predictable bioavailability and pharmacokinetics leading to optimized efficacy and safety.

NEMUS Bioscience Inc., a Nevada corporation, is a SEC fully reporting company listed on the  under the symbol NMUS.

Company Website:  http://www.nemusbioscience.com/home.html

Filings and disclosure with Level 2 quotes:  http://www.otcmarkets.com/stock/NMUS/quote

Contact:

(949) 396-0330
E-MAIL: BRIAN@NEMUSBIO.COM
600 ANTON BLVD, SUITE 1100, COSTA MESA, CA 92626


 

Nemus Bioscience (NMUS) Presentation (47 minutes):  
https://www.youtube.com/watch?v=tYV2PEaj6os

Presentation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 12th, 2016: 
http://s2.q4cdn.com/753474459/files/doc_presentations/2016/Rodman-Conf-September-2016_FINAL.pdf



 


Major press releases:

A Sit Down With Nemus Bioscience; Cannabinoids In Focus Feb. 1, 2017 11:06 AM ET Nemus Bioscience, Inc. (NMUS)  
 

Nemus Bioscience Announces Milestones in the Development of Fully Synthetic Clinical-Grade Active Pharmaceutical Ingredient (API) for Drug Candidates NB1111 and NB2111 and Formulation Contract with AMRI and Catalent Pharma Solutions -


Cannabinoid Drug Advancements Take Off After Quantum Shift in U.S. Drug Policy


Nemus Bioscience Announces Presentation of NB1111 Impact on Intraocular Pressure (IOP) in Normotensive Ocular Model at the National Meeting of the American Association of Pharmaceutical Scientists (AAPS)

 

Nemus Bioscience Announces Enhanced Ocular Tissue Concentration by the Proprietary Prodrug of Tetrahydrocannabinol (NB1111) - Associated With a Superior Decline in Intra-Ocular Pressure (IOP) in an Animal Model

 

Nemus Bioscience, Inc. Announces Letter of Intent to License Biosynthetic Technology to Manufacture Its Proprietary Cannabinoid Molecules From Teewinot Life Sciences Corp.


NEMUS Bioscience Identifies Unique Cannabidiol (CBD) Derivative as a Lead Candidate in Its Neuropathy-Related Pain Management Program 


CANNAINVESTOR Magazine Top 20 Cannabis Stocks 

 

NEMUS Bioscience CEO to Present at the 28th Annual ROTH Conference 

 

NEMUS Bioscience, Inc. Signs Agreement With Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredients 

 

NEMUS Bioscience Prodrug of THC (NB1111) Completes Validation Stage of Glaucoma Testing and Development 

 

Nemus Enters Into Research Agreement With the University of Mississippi to Develop Cannabinoid-Based Therapies for Chemotherapy-Induced Peripheral Neuropathy (CIPN) 

 

NMUS Security Details

Share Structure - as of Feb 1, 2017
Source: otcmarkets.com

Authorized Shares: 236,000,000
Outstanding Shares: 132,414,079 a/o April 18, 2018

      - Restricted  90,689,442
    - Unrestricted  41,724,637

           - Float  14,218,313 a/o April 18, 2018 
   Par Value 0.001


Transfer Agent: Clear Trust, LLC

Digipath
CHM Cannabis
NMUS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NMUS News: Current Report Filing (8-k) 11/16/2018 08:57:16 AM
NMUS News: Small Company Offering and Sale of Securities Without Registration (d) 11/15/2018 07:09:41 AM
NMUS News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 11/14/2018 06:15:18 AM
NMUS News: Quarterly Report (10-q) 11/14/2018 06:15:17 AM
NMUS News: Current Report Filing (8-k) 11/06/2018 07:10:06 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#4862  Sticky Note I was afforded the opportunity to speak with TheMonolith 04/19/18 11:35:50 PM
#5374   Added .3022 today. Looks like this one Brandonworst 12/11/18 09:59:50 PM
#5373   Why? Jdanger 2 12/10/18 07:34:28 PM
#5372   Adding big to my position;) Impacto 12/10/18 01:49:04 PM
#5371   Looks like the political and legal risk of shakeshack 12/10/18 01:25:53 PM
#5370   NMUS presentation from this week: frozenspokes 12/06/18 02:30:22 PM
#5369   http://www.nemusbioscience.com/investor-relations/investor-news/investor-news-de mmjbuyer 12/03/18 11:25:33 AM
#5368   https://insiderfinancial.com/nemus-bioscience-inc-otcmktsnmus-emerald-health frozenspokes 11/26/18 05:19:17 PM
#5366   Wow, up 25% on heavy volume, I was newguy49 11/20/18 01:02:32 PM
#5365   Quite board! shakeshack 11/16/18 10:49:04 AM
#5364   Buying ;) Impacto 11/14/18 01:46:54 PM
#5363   Probably I am sure the 10 million shares drew5 11/09/18 11:27:44 AM
#5362   In what way? Vinpat 11/09/18 11:03:55 AM
#5361   was emerald the buyer yesterday? Southern Gal 11/09/18 10:37:13 AM
#5360   Ok, thanks! haolepopolo 11/09/18 09:00:15 AM
#5359   NMUS is ready to show ya all its TrendTrade2016 11/09/18 06:30:38 AM
#5358   That’s a rarely used satellite office. All of Vinpat 11/09/18 02:30:52 AM
#5357   Just came across this company and I see haolepopolo 11/09/18 12:05:04 AM
#5356   Yeah, NMUS has been on my radar for NumberGuy 11/08/18 10:55:15 PM
#5355   Unless you've been holding since last year you BrophInvest 11/08/18 07:18:20 PM
#5354   We shall see, I got mine at .175 NumberGuy 11/08/18 06:06:05 PM
#5353   If it breaks this next leg of resistance BrophInvest 11/08/18 05:28:01 PM
#5352   Hope I get another entry point because I NumberGuy 11/08/18 05:15:01 PM
#5351   WOW! eight times volume and no news, I newguy49 11/08/18 02:07:50 PM
#5350   Amazing day. Crazy that nobody knows what's going on... Jdanger 2 11/08/18 01:51:58 PM
#5349   Sessions has no impact on Nemus and never Vinpat 11/08/18 01:16:03 PM
#5348   What is going on here!? Something must dragonslayer400 11/08/18 01:13:24 PM
#5347   I have never understood nemus. PotterBanker 11/08/18 01:10:04 PM
#5346   Certainly a nice move... greenwillow 11/08/18 01:01:49 PM
#5345   NMUS Daily GREEN Award. Way to go longs! PotterBanker 11/08/18 12:40:22 PM
#5344   Maybe a coincidence maybe not... 1 year anniversary mmjbuyer 11/08/18 12:38:52 PM
#5343   Nice ... JohnCM 11/08/18 12:16:50 PM
#5342   Glad I stuck around $NMUS jjr04001 11/08/18 10:30:49 AM
#5341   Yes, losing both Pete Sessions and Jeff Sessions NumberGuy 11/08/18 10:29:36 AM
#5340   It certainly wasn't a negative. US cannabis market BrophInvest 11/08/18 10:20:57 AM
#5339   its 10am and NMUS has done 1.4 million shakeshack 11/08/18 10:12:50 AM
#5338   Why the spike? Southern Gal 11/08/18 09:49:23 AM
#5337   Jeff Sessions out as A.G. let's go frozenspokes 11/07/18 03:02:33 PM
#5336   Down goes Pete Sessions!! US Legalization just got NumberGuy 11/06/18 10:33:07 PM
#5335   is emerald buying the shares preparing to take Mandofellow 11/05/18 03:42:21 PM
#5334   When is the promo and news gunna start? shakeshack 11/02/18 02:50:11 PM
#5333   Thanks Jascom 10/31/18 04:55:22 PM
#5332   Emerald is doing a great job of managing shakeshack 10/31/18 02:00:50 PM
#5331   It's a moderate increase and has been known BrophInvest 10/31/18 11:43:22 AM
#5330   I just received a Schedule 14C in my Jascom 10/30/18 10:51:40 PM
#5329   considering how bad the sector is this is a surfer 10/29/18 10:48:32 PM
#5328   Wow $NMUS held up extremely well BrophInvest 10/29/18 04:21:58 PM
#5327   Let's go $NMUS jjr04001 10/26/18 02:44:50 PM
#5326   Double tap the bottom. willlbone 10/26/18 10:26:38 AM
#5325   Nice buy. I picked up 30s BrophInvest 10/25/18 05:57:32 PM
#5324   Got some under 27 cents. willlbone 10/25/18 03:09:10 PM
PostSubject